Clinical Study
Treatment of Basal Cell Carcinomas with Pulsed Dye Laser: A Case Series
Table 1
Basal cell carcinoma and response to pulsed dye laser.
| Patient | Age | Gender | Lesion | Tumor subtype | Location | Number of treatments | Response | Followup (months) |
| 1 | 83 | M | 1 | S/N | L cheek | 3 | C | 25 | 2 | 73 | M | 2 | N | R cheek | 4 | C | 19 | 3 | N | L face | 4 | C | 19 | 4 | N | R jawline | 4 | C | 19 | 5 | N | Chin | 4 | C | 19 | 3 | 53 | F | 6 | N | R forehead | 4 | C | 11 | 4 | 60 | F | 7 | N | R shoulder | 3 | C | 21 | 5 | 83 | F | 8 | MN | R upper lip | 4 | C | 25 | 9 | N | L chin | 4 | C | 25 | 10 | NP | R chin | 4 | C | 25 | 6 | 80 | M | 11 | N | L temple | 3 | L | L | 7 | 85 | M | 12 | K | L forehead | 3 | L | L | 8 | 85 | M | 13 | N | Mid upper lip | 3 | C | 8 | 14 | NU | L upper lip | 3 | C | 8 | 9 | 82 | F | 15 | NI | R nose tip | 4 | R | 15 | 10 | 85 | M | 16 | NI | R nose ala | 4 | C | 5 | 11 | 65 | M | 17 | N | Nose tip | 3 | C | 12 | 12 | 80 | F | 18 | N | L nose ala | 4 | C | 9 | 13 | 63 | M | 19 | NS | L upper lip | 4 | C | 3 | 14 | 80 | F | 20 | N | Nose tip | 4 | Inc | 3 | 15 | 70 | F | 21 | S/N | Lower lip | 3 | C | 6 | 16 | 90 | F | 22 | NU | Nose tip | 2 | C | 25 | 17 | 79 | M | 23 | N | Forehead | 4 | C | 3 | 24 | N | L temple | 4 | C | 3 | 18 | 86 | M | 25 | NI | Mid forehead | 4 | R | 3 | 26 | I | L forehead | 4 | R | 3 | 19 | 54 | F | 27 | NI | Nose tip | 4 | R | 3 | 20 | 30 | F | 28 | N | L cheek | 3 | C | 6 | 21 | 49 | F | 29 | K | L leg | 2 | L | L | 22 | 79 | F | 30 | S/N | L chin | 3 | C | 5 | 23 | 83 | M | 31 | NS | Scalp | 4 | Inc | 3 | 24 | 81 | M | 32 | NI | Mid upper lip | 4 | R | 3 | 25 | 48 | M | 33 | N | R shoulder | 4 | Inc | 3 | 26 | 79 | M | 34 | N | R chin | 3 | L | L | 35 | N | L nose | 3 | L | L | 36 | N | L jawline | 3 | L | L | 27 | 90 | F | 37 | S | L nose ala | 3 | L | L | 28 | 72 | M | 38 | U | L helix ear | 1 | C | 4 | 29 | 81 | M | 39 | N | Nose tip | 1 | C | 18 |
|
|
Pathologic subtypes. S: superficial; S/N: superficial-nodular; N: nodular; MN: micronodular; K: keratinized; NP: nodular-pigmented; NU: nodular-ulcerative; NI: nodular-infiltrative; NS: nodular-sclerotic; I: infiltrative; U: ulcerative. Response. C: complete with at least 3 months followup evaluation; Inc: incomplete response; L: lost to followup; R: recurrence.
|